ReviewFrontiers in neuroendocrinology2026
We must look beyond primary reinforcement to understand nicotine use in women.
Review in Frontiers in neuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Women exhibit greater nicotine use vulnerability than men. Common cessation treatments are less effective for women, suggesting unique contributors to women's smoking that are not fully characterized or targeted by available treatments. High estradiol is associated with enhanced smoking and cessation difficulty, whereas high progesterone is associated with reduced smoking and better cessation success. Hormonal contraceptives can produce similar or even outsized alterations in nicotine use outcomes. Despite clear effects of natural and synthetic sex steroid hormones on nicotine intake, the behavioral pathways by which hormones alter nicotine use outcomes remain unmapped. In this review paper, we propose that uncovering such mechanisms requires examining sex steroid hormone modulation of non-primary reinforcement factors in our animal models. Parallel effects of natural and synthetic sex steroid hormones on nicotine self-administration occur in animal models. Further, women's smoking is more influenced by environmental stimuli, such as the smell, taste, and visual cues associated with nicotine use than by the reinforcing effects of nicotine. In building our case, we first summarize research supporting the import of environmental factors in nicotine intake for women and translation to female rats. We also synthesize findings on how biological sex and sex steroid hormones influence these mechanisms in humans and rats. Lastly, we will detail promising directions for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.